Lyell Immunopharma, Inc. Common Stock Share Price
NASDAQ: LYELHealthcare
Live Lyell Immunopharma, Inc. Common Stock Share Price Chart
O H L
Lyell Immunopharma, Inc. Common Stock Performance Overview
Days Range
▼
$10.60Low
$11.00High
Markets Today
| Previous Close | $10.80 |
|---|---|
| Open | $10.93 |
| Volume | 132,997 |
| Day's Range | $10.60 - $11.00 |
| 52W Range | $10.46 - $45.00 |
| Market Cap | $264.04 M |
Historical Performance
| 1M Returns | -31.60 |
|---|---|
| 3M Returns | -15.23 |
| 6M Returns | -46.16 |
| 1Y Returns | -14.56 |
| 5Y Returns | -95.43 |
| 10Y Returns | NA |
Lyell Immunopharma, Inc. Common Stock Fundamentals
| Market Cap | $264.04 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $36.00 K |
| ROE TTM | -0.87 |
| EPS TTM | $-12.01 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.08 |
| EBITDA | $-192.24 M |
| Profit Margin | -762355.56 |
| Market Cap | $264.04 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $36.00 K |
| ROE TTM | -0.87 |
| EPS TTM | $-12.01 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.08 |
| EBITDA | $-192.24 M |
| Profit Margin | -762355.56 |
Lyell Immunopharma, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $7.00 K | $8.00 K | $15.00 K | $6.00 K | $2.00 K | $4.00 K |
| Gross Profit + | $7.00 K | $8.00 K | $15.00 K | $6.00 K | $2.00 K | $4.00 K |
| Operating Income | -$57.37 M | -$47.14 M | -$37.25 M | -$129.79 M | -$44.26 M | -$47.34 M |
| EBITDA | -$53.93 M | -$42.56 M | -$34.69 M | -$61.06 M | -$41.93 M | -$45.12 M |
| Interest Expense | $3.86 M | $3.28 M | $0 | $0 | $2.19 M | $2.18 M |
| Depreciation | $3.44 M | $4.58 M | $2.57 M | $68.73 M | $2.33 M | $2.22 M |
| Income Before Tax | -$52.20 M | -$42.68 M | -$38.85 M | -$140.72 M | -$24.15 M | -$44.76 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$52.20 M | -$42.68 M | -$38.85 M | -$140.72 M | -$24.15 M | -$44.76 M |
| Net Profit Margin | -745642.86% | -533550% | -258973.33% | -2345383.33% | -1207650% | -1118875% |
Lyell Immunopharma, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $30.00 K | $1.00 K | $2.00 K | $2.00 K | $2.00 K | $2.00 K |
| Reserve & Surplus | -$1.40 B | -$1.44 B | -$1.48 B | -$1.62 B | -$1.64 B | -$1.69 B |
| Non-Current Liabilities | $51.99 M | $49.63 M | $46.97 M | $42.44 M | $40.01 M | $37.47 M |
| Current Liabilities | $41.28 M | $36.90 M | $31.88 M | $49.41 M | $36.95 M | $39.87 M |
| Total Liabilities | $93.28 M | $86.53 M | $78.84 M | $91.85 M | $76.96 M | $77.34 M |
| Fixed Assets | $44.20 M | $39.12 M | $36.72 M | $34.77 M | $32.72 M | $30.51 M |
| Current Assets | $309.18 M | $282.21 M | $328.20 M | $260.94 M | $267.30 M | $213.54 M |
| Total Assets | $429.80 M | $385.45 M | $407.96 M | $340.05 M | $350.63 M | $311.15 M |
Lyell Immunopharma, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$52.20 M | -$42.68 M | -$38.85 M | -$140.72 M | -$24.15 M | -$44.76 M |
| Operating Cash Flow | -$54.74 M | -$34.46 M | -$28.58 M | -$32.25 M | -$38.51 M | -$33.92 M |
| Investing Cash Flow | $69.47 M | $12.65 M | $3.35 M | -$31.36 M | $17.38 M | $15.62 M |
| Financing Cash Flow | $1.00 K | $183.00 K | $50.00 M | $222.00 K | $51.72 M | $522.00 K |
| Change in Cash | $14.73 M | -$21.63 M | $24.77 M | -$63.39 M | $30.59 M | -$17.78 M |
Lyell Immunopharma, Inc. Common Stock Return Calculator
The Lyell Immunopharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$441
Invested Amount$10,000
Est. Returns$-9,559
About Lyell Immunopharma, Inc. Common Stock
Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.
Popular Stocks
FAQs
What is the share price of Lyell Immunopharma, Inc. Common Stock today?
Lyell Immunopharma, Inc. Common Stock (LYEL) share price as of September 18, 2026 is $10.41. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Lyell Immunopharma, Inc. Common Stock?
Yes, Indian Investors can invest in the Lyell Immunopharma, Inc. Common Stock (LYEL) Share by opening an international trading account with Angel One.
How can I purchase Lyell Immunopharma, Inc. Common Stock shares in India?
Purchasing Lyell Immunopharma, Inc. Common Stock (LYEL) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Lyell Immunopharma, Inc. Common Stock (LYEL) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Lyell Immunopharma, Inc. Common Stock?
Yes, you can purchase fractional shares of Lyell Immunopharma, Inc. Common Stock (LYEL) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Lyell Immunopharma, Inc. Common Stock?
The market capitalization of Lyell Immunopharma, Inc. Common Stock on September 18, 2026, is $264.04 M.
In which sector Lyell Immunopharma, Inc. Common Stock belongs?
Lyell Immunopharma, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Lyell Immunopharma, Inc. Common Stock stocks?
In order to invest in Lyell Immunopharma, Inc. Common Stock (LYEL) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
